SEARCH

SEARCH BY CITATION

References

  • Ambudkar S. V., Dey S., Hrycyna C. A., Ramachandra M., Pastan I. & Gottesman M. M. (1999) Biochemical, cellular, and pharmacological aspects of the multidrug transporter. Annu. Rev. Pharmacol. Toxicol. 39, 361398.
  • Brown M. S., Ye J., Rawson R. B. & Goldstein J. L. (2000) Regulated intramembrane proteolysis: a control mechanism conserved from bacteria to humans. Cell 100, 391398.
  • Busciglio J., Gabuzda D. H., Matsudaira P. & Yankner B. A. (1993) Generation of β-amyloid in the secretory pathway in neuronal and nonneuronal cells. Proc. Natl Acad. Sci. USA 90, 20922096.
  • Citron M., Diehl T. S., Gordon G., Biere A. L., Seubert P. & Selkoe D. J. (1996) Evidence that the 42- and 40-amino acid forms of amyloid-β protein are generated from the β-amyloid precursor protein by different protease activities. Proc. Natl Acad. Sci. USA 93, 1317013175.DOI: 10.1073/pnas.93.23.13170
  • Cordon-Cardo C., O'brien J. P., Casals D., Rittman-Grauer L., Biedler J. L., Melamed M. R. & Bertino J. R. (1989) Multidrug resistance gene (p-glycoprotein) is expressed by endothelial cells at blood–brain barrier sites. Proc. Natl Acad. Sci. USA 86, 695698.
  • Croop J. M. (1998) Evolutionary relationships among ABC transporters. Methods Enzymol. 292, 101116.
  • Cummings J. L., Vinters H. V., Cole G. M. & Khachaturian Z. S. (1998) Alzheimer's disease: etiologies, pathophysiology, cognitive reserve, and treatment opportunities. Neurology 51, S2S17.
  • DiDiodato G. & Sharom F. J. (1997) Interaction of combinations of drugs, chemosensitizers, and peptides with the P-glycoprotein multidrug transporter. Biochem. Pharmacol. 53, 17891797.DOI: 10.1016/s0006-2952(97)00007-5
  • Doige C. A. & Sharom F. J. (1992) Transport properties of P-glycoprotein in plasma membrane vesicles from multidrug-resistant Chinese hamster ovary cells. Biochim. Biophys. Acta 1109, 161171.
  • Fojo A. T., Ueda K., Slamon D. J., Poplack D. G., Gottesman M. M. & Pastan I. (1987) Expression of a multidrug-resistance gene in human tumors and tissues. Proc. Natl Acad. Sci. USA 84, 265269.
  • Ford J. M. & Hait W. N. (1990) Pharmacology of drugs that alter multidrug resistance in cancer. Pharm. Rev. 42, 155199.
  • Gottesman M. M. & Pastan I. (1993) Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu. Rev. Biochem. 62, 385427.
  • Grant C. E., Valdimarsson G., Hipfner D. R., Almquist K. C., Cole S. P. & Deeley R. G. (1994) Overexpression of multidrug resistance-associated protein (MRP) increases resistance to natural product drugs. Cancer Res. 54, 357361.
  • Gruol D. J., Zee M. C., Trotter J. & Bourgeois S. (1994) Reversal of multidrug resistance by RU 486. Cancer Res. 54, 30883091.
  • Haass C., Schlossmacher M. G., Hung A. Y., Vigo-Pelfrey C., Mellon A., Ostaszewski B. L., Lieberburg I., Koo E. H., Schenk D. & Teplow D. B. et al. (1992) Amyloid-β peptide is produced by cultured cells during normal metabolism. Nature 359, 322325.
  • Hardy J., Duff K., Hardy K. G., Perez-Tur J. & Hutton M. (1999) Genetic dissection of Alzheimer's disease and related dementias: amyloid and its relationship to tau. Nat. Neurosci. 1, 355358.
  • Higgins C. F. & Gottesman M. M. (1992) Is the multidrug transporter a flippase? TIBS 17, 1821.
  • Ida N., Hartmann T., Pantel J., Schroder J., Zerfass R., Forstl H., Sandbrink R., Masters C. L. & Beyreuther K. (1996) Analysis of heterogeneous A4 peptides in human cerebrospinal fluid and blood by a newly developed sensitive Western blot assay. J. Biol. Chem. 271, 2290822914.
  • Juliano R. L. & Ling V. (1976) A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochem. Biophys. Acta 455, 152162.
  • Kuchler K. & Thorner J. (1992) Secretion of peptides and proteins lacking hydrophobic signal sequences: the role of adenosine triphosphate-driven membrane translocators. Endocr. Rev. 13, 499514.
  • Lin X., Koelsch G., Wu S., Down S., Daisha A. & Tang J. (2000) Human aspartic protease memapsin 2 cleaves the β-secretase site of β-amyloid precursor protein. Proc. Natl Acad. Sci. USA 97, 14561460.DOI: 10.1073/pnas.97.4.1456
  • Liu R. & Sharom F. J. (1996) Site-directed fluorescence labeling of P-glycoprotein on cysteine residues in the nucleotide binding domains. Biochemistry 35, 1186511873.
  • Marsaud V., Mercier-Bodard C., Fortin D., Le Bihan S. & Renoir J. M. (1998) Dexamethasone and triamcinolone acetonide accumulation in mouse fibroblasts is differently modulated by the immunosuppressants cyclosporin A, FK506, rapamycin and their analogues, as well as by other P-glycoprotein ligands. J. Steroid. Biochem. Mol. Biol. 66, 1125.DOI: 10.1016/s0960-0760(98)00008-9
  • Mills J., Charest D. L., Lam F., Beyreuther K., Ida N., Pelech S. L. & Reiner P. B. (1997) Regulation of amyloid precursor protein catabolism involves the mitogen-activated protein kinase signal transduction pathway. J. Neurosci. 17, 94159422.
  • Mills J. A. & Reiner P. B. (1999) Regulation of amyloid precursor protein cleavage. J. Neurochem. 72, 443460.
  • Pardridge W. M., Golden P. L., Kang Y.-S. & Bickel U. (1997) Brain microvascular and actrocyte localization of p-glycoprotein. J. Neurochem. 68, 12781285.
  • Pastan I., Gottesman M. M., Ueda K., Lovelace E., Rutherford A. V. & Willingham M. C. (1988) A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells. Proc. Natl Acad. Sci. USA 85, 44864490.
  • Price D. L., Sisodia S. S. & Borchelt D. R. (1998) Genetic neurodegenerative diseases: the human illness and transgenic models. Science 282, 10791083.
  • Regina A., Romero I A., Greenwood J., Adamson P., Boure J. H., Courand P. O. & Roux F. (1999) Dexamethasone regulation of P-glycoprotein activity in an immortalized rat brain endothelial cell line, GPNT. J. Neurochem. 73, 19541963.
  • Selkoe D. J. (1999) Translating cell biology into therapeutic advances in Alzheimer's disease. Nature 399, A23A31.
  • Seubert P., Vigo-Pelfrey C., Esch F., Lee M., Dovey H., Davis D., Sinha S., Schlossmacher M., Whaley J. & Swindlehurst C. et al. (1992) Isolation and quantification of soluble Alzheimer's β-peptide from biological fluids. Nature 359, 325327.
  • Shapiro A. B. & Ling V. (1995) Reconstitution of drug transport by purified P-glycoprotein. J. Biol. Chem. 270, 1616716175.
  • Sharom F. J., Yu X. & Doige C. A. (1993) Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein. J. Biol. Chem. 268, 2419724202.
  • Sharom F. J., DiDiodato G., Yu X. & Ashbourne K. J. (1995a) Interaction of the P-glycoprotein multidrug transporter with peptides and ionophores. J. Biol. Chem. 270, 1033410341.
  • Sharom F. J., Yu X., Chu J. W. & Doige C. A. (1995b) Characterization of the ATPase activity of P-glycoprotein from multidrug-resistant Chinese hamster ovary cells. Biochem. J. 308, 381390.
  • Sharom F. J., Yu X., DiDiodato G. & Chu J. W. (1996) Synthetic hydrophobic peptides are substrates for P-glycoprotein and stimulate drug transport. Biochem. J. 320, 421428.
  • Sharom F. J., Liu R. & Romsicki Y. (1998a) Spectroscopic and biophysical approaches for studying the structure and function of the P-glycoprotein multidrug transporter. Biochem. Cell. Biol. 76, 695708.
  • Sharom F. J., Lu P., Liu R. & Yu X. (1998b) Linear and cyclic peptides as substrates and modulators of P-glycoprotein: peptide binding and effects on drug transport and accumulation. Biochem. J. 333, 621630.
  • Sharom F. J., Yu X., Lu P., Liu R., Chu J. W., Szabo K., Muller M., Hose C. D., Monks A., Varadi A., Seprodi J. & Sarkadi B. (1999) Interaction of the P-glycoprotein multidrug transporter (MDR1) with high affinity peptide chemosensitizers in isolated membranes, reconstituted systems, and intact cells. Biochem. Pharmacol. 58, 571586.DOI: 10.1016/s0006-2952(99)00139-2
  • Shoji M., Golde T. E., Ghiso J., Cheung T. T., Estus S., Shaffer L. M., Cai X. D., McKay D. M., Tintner R. & Frangione B. et al. (1992) Production of the Alzheimer amyloid-β protein by normal proteolytic processing. Science 258, 126129.
  • Terzi E., Holzemann G. & Seelig J. (1995) Self-association of β-amyloid peptide (1–40) in solution and binding to lipid membranes. J. Mol. Biol. 252, 633642.DOI: 10.1006/jmbi.1995.0525
  • Terzi E., Holzemann G. & Seelig J. (1997) Interaction of Alzheimer β-amyloid peptide (1–40) with lipid membranes. Biochemistry 36, 1484514852.
  • Thiebaut F., Tsuruo T., Hamada H., Gottesman M. M., Pastan I. & Willingham M. C. (1987) Cellular localization of the multidrug-resistance gene product P-glycoprotein in normal human tissues. Proc. Natl Acad. Sci. USA 84, 77357738.
  • Vasser R. et al. (1999) β-Secretase cleavage of Alzheimer's amyloid precursor protein by the transmembrane aspartic protease BACE. Science 286, 735741.DOI: 10.1126/science.286.5440.735
  • Van Veen H. W. & Konings W. N. (1998) The ABC family of multidrug transporters in microorganisms. Biochim. Biophys. Acta 1365, 3136.
  • Wehling M. (1994) Nongenomic actions of steroid hormones. Trends Endocrinol. Metab. 5, 347353.
  • Wolfe M. S., Xia W., Ostaszewski B. L., Diehl T. S., Kimberly W. T. & Selkoe D. J. (1999) Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and γ-secretase activity. Nature 398, 513517.DOI: 10.1038/19077
  • Yakushi T., Masuda K., Narita S.-I. & Tokuda H. (2000) A new ABC transporter mediating the detachment of lipid-modified proteins from membranes. Nat. Cell Biol. 2, 212218.DOI: 10.1038/35008635